CODE EYE CARE

Your Eye Surface Can Be Affected in Many Ways. We Diagnose and Treat All of Them.

Comprehensive Care for Dry Eye, Autoimmune Eye Disease & Complex Ocular Surface Disorders.

Group 922

Global Referral Centre for Complex Ocular Surface Disorders & Keratoprosthesis (KPro)

Years Combined Experience
0 +
Successful Procedures
0 k+
International
Awards
0 +
Research
Papers
0 +

What Are Ocular Surface Disorders?

Ocular surface disorders affect the front layer of the eye, the cornea, conjunctiva, eyelids, and tear film that keeps the eye moist and protected.

When this system breaks down, it causes irritation, dryness, and vision problems.

These conditions range from everyday dryness to severe, sight-threatening diseases  and each requires a different approach.

You may have an ocular surface disorder if:

What Relief Actually Feels Like

Patient Success Stories

Stories from patients from across the globe with severe ocular surface disease, dry eye, Stevens-Johnson syndrome, and complex corneal conditions.

Meet Your Ocular Surface Specialists in Chennai

Dr Geetha Iyer

Medical Director, CODE Eye Care

20+ years of experience in managing dry eye and complex ocular surface disorders. Expert in advanced diagnostic evaluation and long-term treatment planning. Specialised in chronic and treatment-resistant eye conditions. Board Member, Tear Film & Ocular Surface Society (TFOS) Steering Committee Member – International KPro Study Group.

Group 918

Dr Bhaskar Srinivasan

Senior Ophthalmologist | Cornea Specialist

20+ years of experience in corneal diseases and ocular surface management. Evidence-based approach to treatment and surgical care. Manages advanced and referral-level cases. India Ambassador – Tear Film & Ocular Surface Society (TFOS) Steering Committee Member – International KPro Study Group.

Group 920

Advanced Ocular Surface Treatment Options

Treatment is selected based on your diagnosis, severity, and response to prior care. We begin with the least invasive approach and escalate only when needed.

Rectangle 21653
  • Targeted lubrication strategies
  • Anti-inflammatory therapy
  • Tear film stabilisation
Rectangle 21650
  • Punctal Occlusion
  • Punctal Cautery
Rectangle 21656
  • Lid margin disease treatment
  • MGD therapy, including Intense Pulsed Light (IPL) & Thermal Therapy
Rectangle 21664
  • Autologous Serum Tears
  • Ocular surface reconstruction approaches
Rectangle 21663
  • Systemic and topical immune-based treatment for autoimmune eye disease
  • Coordinated care with rheumatologists, nephrologists, dermatologists, and immunologists
Rectangle 21665
  • Amniotic Membrane Grafting
  • Mucus Membrane Graft
  • Limbal Cell Procedures — SLET / AlloSLET
  • Corneal Transplantation — High-Risk Grafts
  • Keratoprosthesis (KPro) — Type 1 & 2  KPro, MOOKP, Auro KPro for cases where standard transplants are not suitable

Types Of Ocular Surface Diseases We Treat

Common Ocular Surface Conditions

Rectangle 21671
  • Dry Eye Disease
  • Meibomian Gland Dysfunction (MGD)
  • Blepharitis
  • Allergic Eye Disease
  • Pterygium
  • Demodex Infestation
  • Chalazion & Stye
  • Insufficient or unstable tears causing persistent discomfort
  • Blocked oil glands causing tears to evaporate too fast
  • Chronic eyelid inflammation with crusting and redness
  • Seasonal or environmental triggers causing redness and itching
  • UV-related tissue growth on the eye surface causing irritation
  • Microscopic mites on eyelids causing persistent irritation
  • Painful eyelid lumps from blocked glands

Autoimmune & Inflammatory Disorders

Rectangle 21697
  • Sjögren’s Disease
  • Rheumatoid Arthritis-Related Eye Disease
  • SLE (Lupus)
  • Scleritis
  • Uveitis
  • Hydroxychloroquine Screening
  • PUK / Mooren’s Ulcer
  • An autoimmune condition where the body attacks its own tear glands
  • Joint disease that can also affect the eye surface
  • Systemic autoimmune disease with potential eye involvement
  • Painful inflammation of the white of the eye
  • Internal eye inflammation that can affect the surface
  • Eye monitoring for patients on long-term hydroxychloroquine therapy

Severe Ocular Surface Disorders

Rectangle 21676
  • Stevens-Johnson Syndrome (SJS)
  • Ocular Cicatricial Pemphigoid (OCP) / Mucous Membrane Pemphigoid
  • Graft-vs-Host Disease (GVHD)
  • Limbal Stem Cell Deficiency (LSCD)
  • A severe reaction that can cause permanent eye surface scarring
  • An autoimmune condition causing progressive scarring of the eye surface
  • Eye complications following bone marrow or stem cell transplant
  • Loss of the cells that maintain a clear, healthy corneal surface

Injury-Related Conditions

Rectangle 21681
  • Chemical Injuries
  • Thermal Burns
  • Emergency care and long-term rehabilitation after chemical exposure
  • Surface damage caused by heat or steam requiring specialised care

Surface Tumours

Rectangle 21686
  • Ocular Surface Squamous Neoplasia (OSSN)
  • Conjunctival Nevus and other pigmented lesions 
  • Dermoid 
  • Conjunctival Lymphoma 
  • Other ocular surface tumors
  • Abnormal cell growth on the eye surface requiring accurate diagnosis and treatment

Surface Tumours

Group 883 1
  • Neurotrophic Keratopathy
  • Conjunctivochalasis
  • Recurrent Corneal Erosions
  • Post-Surgical Complications
  • Reduced corneal sensation leading to surface breakdown
  • Loose conjunctival tissue causing irritation and tearing
  • Repeated episodes of surface damage causing pain and sensitivity
  • Ocular surface issues following previous eye surgery

Get expert evaluation and treatment for dry eyes, irritation, and ocular surface disorders before they affect your vision.

Stories That Sound Like Yours

image 33

Comprehensive Eye Surface Care, From Diagnosis to Advanced Treatment

We treat both common and complex ocular surface diseases, including cases referred after incomplete recovery or uncertain diagnosis.

Dry eye is often the initial concern, but many individuals have a broader ocular surface disorder that requires a more comprehensive evaluation.

At CODE Eye Care, we follow a global, evidence-based approach to treating ocular surface disorders.

Our team is actively involved in international academic collaborations, research, education, and advanced ocular surface rehabilitation.

Our Approach:

Frequently Asked Questions

Is ocular surface disorder the same as dry eye?

No. Dry eye is one type of ocular surface disorder. You may also have meibomian gland dysfunction, autoimmune disease, limbal stem cell deficiency, or a combination of conditions. Generic eye drops often don’t help because they don’t address the root cause.

Most patients see improvement within 4–12 weeks. Timelines depend on the severity and underlying diagnosis. Chronic conditions may need ongoing management.

It depends on your condition. Some patients achieve full relief with short-term treatment. Others with chronic conditions such as autoimmune-related eye disease or MGD may need long-term management, similar to managing blood pressure or diabetes. We create sustainable plans that fit your routine.

Most patients don’t. We start with non-surgical treatments, medications, lifestyle changes, and in-office procedures. Surgery is considered only when clinically necessary, and we’ll explain exactly why and what to expect.

Costs vary based on diagnosis and severity. Standard medical treatments are covered by insurance. Advanced procedures may have out-of-pocket components. We’ll outline a clear treatment plan with cost estimates at your first visit.

If over-the-counter drops aren’t helping, symptoms are worsening, you have pain or vision changes, or your diagnosis remains unclear, it’s time to see a specialist.

Yes. We regularly see patients referred by ophthalmologists, optometrists, rheumatologists, and dermatologists. A referral is not required, but is accepted.

We ger referrals from across the country and the world for management of Ocular surface disorders.

Yes, if left untreated. Severe ocular surface disorders can damage the cornea and affect long-term vision. Early evaluation matters.

Many of our patients come after trying several treatments elsewhere without lasting relief. We specialise in conditions that haven’t responded to standard care.

No. While some changes occur with age, persistent symptoms indicate a treatable condition  not an inevitable one.

Even without symptoms, certain individuals are at higher risk of developing ocular surface disorders and may benefit from early screening.

This includes:

  • Heavy screen users
  • Patients with long-term digital exposure
  • Contact lens users
  • LASIK candidates
  • Patients with Sjögren’s Disease
  • Patients with Rheumatoid Arthritis
  • Individuals with chronic eye strain or fluctuating vision


Early evaluation helps identify tear film instability, gland dysfunction, or surface damage before symptoms become severe.

People with heavy screen exposure, contact lens use, autoimmune disease, or those planning LASIK may benefit from preventive screening, even if symptoms are mild or absent.

Yes. Conditions like Sjögren’s Disease, Rheumatoid Arthritis, and Lupus can affect tear production and ocular surface health, leading to chronic dryness, inflammation, and surface damage.

Punctal occlusion is a procedure that helps retain natural tears by partially blocking tear drainage channels. It is commonly recommended for moderate-to-severe dry eye cases where lubrication alone is not enough.

Scroll to Top

Book an Appointment

Contact us